Coleman, Robert L ;
Fleming, Gini F ;
Brady, Mark F...
Coleman , R L , Fleming , G F , Brady , M F , Swisher , E M , Steffensen , K D , Friedlander , M , Okamoto , A , Moore , K N , Efrat Ben-Baruch , N , Werner , T L , Cloven , N G , Oaknin , A , DiSilvestro , P A , Morgan , M A , Nam , J-H , Leath , C A , Nicum , S , Hagemann , A R , Littell , R D , Cella , D , Baron-Hay , S , Garcia-Donas , J , Mizuno , M , Bell-McGuinn , K , Sullivan , D M , Bach , B A , Bhattacharya , S , Ratajczak , C K , Ansell , P J , Dinh , M H , Aghajanian , C & Bookman , M A 2019 , ' Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer ' , The New England Journal of Medicine , vol. 381 , no. 25 , pp. 2403-2415 . https://doi.org/10.1056/NEJMoa1909707.
,
2019
